Conagen

Conagen

Synthetic Biology And Biological Engineering Company.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

€0.0

round

$30.0m

Late VC
Total Funding000k
Notes (0)
More about Conagen
Made with AI
Edit

Founded in 2010 by Dr. Oliver Yu, Conagen is a vertically integrated synthetic biology and biotechnology company. Dr. Yu, the company's CEO, brings extensive experience in metabolic engineering, with a background that includes a Ph.D. from the University of South Carolina, postdoctoral training at DuPont, and a tenure as a Principal Investigator at the Donald Danforth Plant Science Center. His academic and research career, which includes over 120 manuscripts and patents, is foundational to Conagen's scientific approach.

The company operates by using synthetic biology and precision fermentation to manufacture high-value ingredients for a diverse client base. Its business model focuses on providing these bio-manufactured products to companies in the food and beverage, flavor and fragrance, nutrition, pharmaceutical, and renewable materials sectors. Conagen generates revenue by serving these business-to-business markets, leveraging its vertically integrated structure that encompasses everything from initial strain development to commercial-scale production, ensuring speed to market.

Conagen's core service is the development and production of natural products through advanced biological processes. The company engineers microorganisms and utilizes fermentation to create a wide array of molecules, including natural sweeteners, flavors, fragrances, nutraceuticals, and specialty chemicals. Key technological capabilities include strain development, metabolic pathway engineering, and fermentation process development. The company has established proprietary production platforms for major molecular classes like terpenoids, phenolics, and lipids, and uses high-throughput automation and robotics to screen vast numbers of microbial strains efficiently. This bio-manufacturing approach allows for the sustainable and scalable production of ingredients that may be difficult to source through traditional agriculture or chemical synthesis. A significant milestone was a $30 million strategic investment from Sumitomo Chemical in 2020, aimed at accelerating research and developing sustainable chemicals.

Keywords: synthetic biology, biotechnology, fermentation, metabolic engineering, natural ingredients, food and beverage, flavors and fragrances, nutrition, pharmaceuticals, renewable materials, bio-manufacturing, strain development, Oliver Yu, sustainable chemicals, sweeteners, nutraceuticals, specialty chemicals, bioconversion, terpenoids, phenolics, lipids, bio-based products, microbial fermentation, industrial biotechnology, green chemistry

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo